Company intelligence / Profile preview

MARC-CRO

Riyadh, Riyadh, Saudi Arabia

Ownership: Private
Employees: ~50
Development stage: Other

Overview

MARC-CRO is a full-service Clinical Research Organization (CRO) that provides comprehensive clinical trial management and regulatory consulting services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in managing Phase I through Phase IV clinical trials, offering expertise in study design, site selection, monitoring, data management, and biostatistics. MARC-CRO is particularly noted for its focus on the Middle East and North Africa (MENA) region, helping global sponsors navigate local regulatory landscapes and patient recruitment. Their service portfolio is designed to accelerate drug development timelines while ensuring high-quality data and compliance with international standards.

Industry: Contract Research Organization

Beyond the preview

Go deeper on MARC-CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MARC-CRO.

Explore the full profile